In a 66-year-old woman with normocytic anemia (hemoglobin 10.2 g/dL, MCV 90 fL), recent fatigue, unremarkable physical exam, peripheral blood smear showing schistocytes, normal ferritin, vitamin B12 and folate levels, and a low reticulocyte index (1.3 %), what is the most likely diagnosis?

Microangiopathic Hemolytic Anemia Due to Severe Vitamin B12 Deficiency (Pseudo-TMA)

The most likely diagnosis is severe vitamin B12 deficiency causing pseudothrombotic microangiopathy (pseudo-TMA), despite the B12 level appearing "normal" at 440 pg/mL, because this presentation with normocytic anemia, schistocytes, low reticulocyte index, and normal iron stores is pathognomonic for this condition when other causes are excluded.

Algorithmic Reasoning

Step 1: Classify the Anemia by MCV and Reticulocyte Response

This patient has normocytic anemia (MCV 90 fL) with a low reticulocyte index (1.3%, below the normal range of 1.0-2.0) 1. According to guideline-based classification:

• Normocytic anemia with low reticulocyte count indicates decreased RBC production, suggesting iron deficiency, vitamin B12/folate deficiency, aplastic anemia, or bone marrow dysfunction 1
• The low reticulocyte index is critical—it excludes hemolysis as the primary process and points toward a production defect 2

Step 2: Evaluate for Nutritional Deficiencies

The laboratory values show:

• Ferritin 120 ng/mL: Normal, excludes iron deficiency 1
• Folate 12: Normal, excludes folate deficiency
• Vitamin B12 440 pg/mL: This appears "normal" by standard cutoffs (typically >200-250 pg/mL), but this is a critical pitfall

Step 3: Recognize the Schistocytes as the Key Diagnostic Clue

The presence of schistocytes with a LOW reticulocyte count is the pathognomonic feature that distinguishes pseudo-TMA from true thrombotic microangiopathy 3, 4, 5.

In true TMA (TTP, HUS, DIC):

• Reticulocyte count is elevated (bone marrow responds appropriately to hemolysis)
• Hemolysis is the primary mechanism

In pseudo-TMA from B12 deficiency:

• Reticulocyte count is low or inappropriately normal (ineffective erythropoiesis)
• Schistocytes result from intramedullary hemolysis and fragile megaloblastic RBCs 4, 5, 6

Step 4: Understand Why B12 440 pg/mL Can Still Represent Severe Deficiency

Critical pitfall: Serum B12 levels between 200-400 pg/mL represent a "gray zone" where tissue deficiency can exist despite seemingly normal levels 3, 7. The most recent research (2024) demonstrates that:

• Patients with pseudo-TMA can have B12 levels that appear borderline or even "normal" by laboratory reference ranges 3, 7
• Methylmalonic acid (MMA) and homocysteine levels are the definitive tests—MMA >0.4 μmol/L confirms tissue B12 deficiency even when serum B12 appears adequate 5, 8
• LDH levels are typically markedly elevated (>2500 IU/L) in B12 deficiency with pseudo-TMA, much higher than in true TMA 5

Step 5: Additional Confirmatory Features

Look for these specific findings that support pseudo-TMA:

• Hypersegmented neutrophils on peripheral smear (>5 lobes) 4, 8
• Macroovalocytes may coexist with normocytic indices if there's concurrent iron deficiency or inflammation 2
• Pancytopenia (not just anemia) is common in severe B12 deficiency 7, 8
• Marked poikilocytosis with tear drop cells 3, 5
• Extremely elevated LDH (often >5000-10,000 IU/L) 5, 8
• Low haptoglobin from intramedullary hemolysis 1

Immediate Next Steps

1. Order MMA and homocysteine levels immediately—these will be markedly elevated and confirm tissue B12 deficiency 5, 8
2. Check LDH, haptoglobin, and indirect bilirubin—expect very high LDH (>2500 IU/L), low haptoglobin, elevated indirect bilirubin 5, 6
3. Review peripheral smear for hypersegmented neutrophils—their presence is diagnostic 4, 8
4. Check anti-intrinsic factor antibodies and anti-parietal cell antibodies to confirm pernicious anemia as the underlying cause 4, 5

Treatment

Begin intramuscular cyanocobalamin 1000 μg daily immediately—do not wait for confirmatory testing if clinical suspicion is high 3, 7, 4. The response is dramatic:

• Reticulocyte count rises within 3-5 days (reticulocyte crisis)
• Hemoglobin improves within 1-2 weeks
• Schistocytes disappear within 2 weeks
• Neurological symptoms improve over weeks to months 5, 8

Critical Pitfall to Avoid

Do NOT initiate plasmapheresis or caplacizumab as you would for TTP 3, 7. The combination of:

• Schistocytes + thrombocytopenia + elevated LDH = high PLASMIC score
• This can lead to misdiagnosis as TTP and inappropriate, expensive, and potentially harmful treatment 3, 4

The key differentiating feature is the LOW reticulocyte count—this should immediately redirect your thinking away from true TMA toward a production defect with pseudo-TMA 4, 5, 6.

Why Other Diagnoses Are Less Likely

• True TMA/TTP: Would have elevated reticulocyte count, not low 3, 4
• Myelodysplastic syndrome: Possible but less likely at age 66 without other cytopenias mentioned; B12 deficiency is far more common and treatable 1, 2
• Anemia of chronic disease: Would not produce schistocytes 1, 2
• Occult malignancy: Possible but would not explain the specific constellation of findings; pursue if B12 replacement fails 1